Current management of symptomatic intracranial stenosis: Medical versus endovascular therapy

Current Atherosclerosis Reports

Volumn 9, Issue 4, 2007, Pages 296-304

  Weigele, John B ^a   Taylor, Robert A ^b   Kasner, Scott E ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITINOL; PLACEBO; WARFARIN;

ARTERY DISSECTION; ARTERY RUPTURE; BALLOON DILATATION; BLEEDING; CAROTID ARTERY OBSTRUCTION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EXTRAINTRACRANIAL ANASTOMOSIS; GENDER; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; INTERNAL CAROTID ARTERY OCCLUSION; LOW DRUG DOSE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RECURRENCE RISK; RETINA BLOOD VESSEL OCCLUSION; REVIEW; SECONDARY PREVENTION; STROKE; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANGIOPLASTY, BALLOON; ANTICOAGULANTS; CEREBRAL ANGIOGRAPHY; CLINICAL TRIALS AS TOPIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; STENTS; STROKE;

EID: 36048947236     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-007-0036-1     Document Type: Review

References (44)

1. Wityk RJ, Lehman D, Klag M, et al.: Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996, 27:1974-1980.
2. Feldmann E, Daneault N, Kwan E, et al.: Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990, 40:1541-1555.
3. Sacco RL, Kargman DE, Gu Q, et al.: Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995, 26:14-20.
4. Chimowitz MI: Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch Neurol 2001, 58:1690-1692.
5. Gomez CR, Orr SC: Angioplasty and stenting for primary treatment of intracranial arterial stenoses. Arch Neurol 2001, 58:1687-1690.
6. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004, 35:1388-1392.
7. Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology 2003, 22:106-117.
8. Chimowitz MI, Kokkinos J, Strong J, et al.: The Warfarin-Aspirin Symptomatic Intracranial. Disease Study. Neurology 1995, 45:1488-1493.
9. Higashida RT, Meyers PM, Connors JJ, et al.: Intracranial angioplasty & stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. J Vasc Interv Radiol 2005, 16:1281-1285.
10. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985, 313:1191-1200.
11. Komotar RJ, Wilson DA, Mocco J, et al.: Natural history of intracranial atherosclerosis: a critical review. Neurosurgery 2006, 58:595-601; discussion 595-601.
12. Chimowitz; MI, Lynn Mj, Howlett-Smith H, et al.: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005, 352:1305-1316.
13. Sundt TM Jr, Siekert RG, Piepgras DG, et al.: Bypass surgery for vascular disease of the carotid system. Mayo Clin Proc 1976, 51:677-692.
14. Friedman JA, Piepgras DG: Current neurosurgical indications for saphenous vein graft bypass. Neurosurg Focus 2003, 14:e1.
15. Amin-Hanjani S, Butler WE, Ogilvy CS, et al.: Extracranial-intracranial bypass in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in the United States between 1992 and 2001: a population-based study. J Neurosurg 2005, 103:794-804.
16. Bencsch CG, Chimowitz MI: Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology 2000, 55:465-466.
17. Millikan CH, Sickert RG, Shick RM: Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Mayo Clin Proc 1955, 30:116-126.
18. Mohr JP, Thompson JL, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444-1451.
19. Kasner SE, Lynn Mj, Chimowitz MI, et al.: Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006, 67:1275-1278.
20. Kasner SE, Chimowitz MI, Lynn MJ, et al.: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006, 113:555-563.
21. Diener HC, Cunha L, Forbes C, et al.: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1-13.
22. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996, 348:1329-1339.
23. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al.: High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 2006, 355:549-559.
24. Nissen SE, Nicholls Sj, Sipahi I, et al.: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006, 295:1556-1565.
25. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al.: Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 2006, 113:2826-2834.
26. Kwon SU, Cho Yj, Koo JS, et al.: Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controtled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005, 36:782-786.
27. Dotter CT, judkins MP: Transluminal treatment of arteriosclerotic obstruction. description of a new technic and a preliminary report of its application. Circulation 1964, 30:654-670.
28. Sundt TM Jr, Smith HC, Campbell JK, et al.: Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980, 55:673-680.
29. O'Leary DH, Clouse ME: Percutaneous transluminal angioplasty of the cavernous carotid artery for recurrent ischemia. Am J Neuroradiol 1984, 5:644-645.
30. Chaloupka JC, Weigele JB, Mangla S, et al.: Cerebrovascular angioplasty and stenting for the prevention of stroke. Curr Neurol Neurosci Rep 2001, 1:39-53.
31. Connors ii 3rd, Wojak JC: Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999, 91:415-423.
32. Marks MP, Wojak JC, Al-Ali F, et al.: Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006, 37:1016-1020.
33. Gomez CR, Misra VK, Liu MW, et al.: Elective stenting of symptomatic basilar artery stenosis. Stroke 2000, 31:95-99.
34. Kim JK, Alm JY, Lee BH, et al.: Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004, 75:847-851.
35. Kim DJ, Lee BH, Kim DI, et al.: Stent-assisted angioplasty of symptomatic intracranial. vertebrobasilar artery stenosis: feasibility and follow-up results. Am J Neuroradiol 2005, 26:1381-1388.
36. Henkes H, Miloslavski E, Lowens S, et al.: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005, 47:222-228.
37. Chow MM, Masaryk Tj, Woo HH, et al.: Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. Am J Neuroradiol 2005, 26:869-874.
38. Weber W, Mayer TE, Henkes H, et al.: Stent-angioplasty of intracranial vertebral and basilar artery stenoses in symptomatic patients. Eur J Radiol 2005, 55:231-236.
39. Jiang WJ, Wang YJ, Du B, et al.: Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004, 35:1375-1380.
40. Abou-Chebl A, Bashir Q, Yadav JS: Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 2005, 36:e165-168.
41. Qureshi Al, Kirmani JF, Hussein HM, et al.: Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006, 59:1044-1051; discussion 1051.
42. Levy EI, Horowitz MB, Koebbe CJ, et al.: Transluminal stent-assisted angiplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001, 48:1215-1221; discussion 1221-1223.
43. Lee TH, Kim DH, Lee BH, et al.: Preliminary results of endovascular stent-assisted angioplasty for symptomatic middle cerebral artery stenosis. Am J Neuroradiol 2005, 26:166-174.
44. Bose A: The Wingspan study. Paper presented at the American Society of Neuroradiology 43rd Annual Meeting. Toronto, Canada; May 23-27, 2005.